Early pharmacotherapy for type 2 diabetes

被引：0
|
作者：
Westphal K. [1 ]
机构：
[1] Freie Medizinjournalistin, Heimstetten
来源：
MMW - Fortschritte der Medizin | 2023年 / 165卷 / 19期
关键词：
D O I：
10.1007/s15006-023-3100-z
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：18 / 18
相关论文
共 50 条
  • [31] Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes
    Anan S. Jarab
    Reham Almrayat
    Salam Alqudah
    Ekbal Thehairat
    Tareq L. Mukattash
    Maher Khdour
    Sharrel Pinto
    International Journal of Clinical Pharmacy, 2014, 36 : 725 - 733
  • [32] Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus
    Alawdi, Shawqi H.
    Al-Dholae, Mohammed
    Al-Shawky, Salah
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2024, 5
  • [33] Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
    James Xu
    Rohan Rajaratnam
    Cardiovascular Diabetology, 16
  • [34] The Genetic Architecture of Type 2 Diabetes Pharmacotherapy: The Emerging Genomic Evidence
    Kavvoura, F. K.
    Pappa, M.
    Evangelou, E.
    Ntzani, E. E.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (22) : 3610 - 3619
  • [35] Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes
    Jarab, Anan S.
    Almrayat, Reham
    Alqudah, Salam
    Thehairat, Ekbal
    Mukattash, Tareq L.
    Khdour, Maher
    Pinto, Sharrel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (04) : 725 - 733
  • [36] Time to treatment intensification in patients on dual pharmacotherapy for type 2 diabetes
    Roberto, Giuseppe
    Barone-Adesi, Francesco
    Giorgianni, Francesco
    Pizzimenti, Valeria
    Bartolini, Claudia
    Magnani, Corrado
    Maggini, Marina
    Da Cas, Roberto
    Spila-Alegiani, Stefania
    Ferrajolo, Carmen
    Francesconi, Paolo
    Trifiro, Gianluca
    Poluzzi, Elisabetta
    Baccetti, Fabio
    Gini, Rosa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 180 - 180
  • [37] Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes
    Xu, James
    Rajaratnam, Rohan
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [38] Trends in Type 2 Diabetes Pharmacotherapy and Evolving Use of the Newer Agents
    Bae, Jay P.
    Liu, Dongju
    Chinthammit, Chanadda
    Kadziola, Zbigniew A.
    Boye, Kristina
    Mather, Kieren J.
    DIABETES, 2021, 70
  • [39] Shared Decision Making, Diagnostic Evaluation, and Pharmacotherapy in Type 2 Diabetes
    Brockamp, Christina
    Landgraf, Ruediger
    Mueller, Ulrich Alfons
    Mueller-Wieland, Dirk
    Petrak, Frank
    Uebel, Til
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2023, 120 (47): : 804 - 810
  • [40] An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
    Mahgoub, Mohamed Omer
    Ali, Ifrah Ismail
    Adeghate, Jennifer O. O.
    Tekes, Kornelia
    Kalasz, Huba
    Adeghate, Ernest A. A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
12345